|
20 Sep 2025 |
ICICI Bank
|
Consensus Share Price Target
|
1402.20 |
1683.95 |
- |
20.09 |
buy
|
|
|
|
|
31 Oct 2017
|
ICICI Bank
|
Reliance Securities
|
1402.20
|
284.00
|
299.95
(367.48%)
|
Target met |
Hold
|
|
|
We expect the Bank's stressed assets and credit cost to rise significantly in 2HFY18, as divergence is likely to be much higher and in-line with other private corporate lenders i.e. Yes Bank & Axis Bank. Its stressed asset portfolio remains uncomfortable at high level of 12.4%, which is one of the highest among large private sector peers. Further, 4.1% of stressed loans are from drilldown list and standard restructured portfolios on which the Bank holds lower PCR. Its specific PCR on gross NPA portfolio also remains lower at 45.8%. Thus, we expect credit cost to remain elevated, which would keep its earnings and return ratio subdued over next 4-6 quarters. Hence, we maintain our HOLD recommendation on the stock with an unrevised...
|
|
30 Oct 2017
|
ICICI Bank
|
Centrum Broking
|
1402.20
|
340.00
|
316.65
(342.82%)
|
Target met |
Buy
|
|
|
ICICI Bank
We retain BUY on ICICI Bank with SOTP based TP unchanged at Rs340. Q2'18 results saw yet another quarter of strong earnings (NII up 8.7% YoY / NIM +14bps YoY to 3.27%), accelerated loan growth (domestic loans up 13.2% YoY) and sequential decline in slippages (3.9% of loans). Drill-down list has more than halved over FY16-Q2FY18 (4.5% of loans). Commentary on overall NPA accretion remains soothing; resolutions in certain large NPA cases could add positively to overall NPA trend. Capital position remains strong while subsidiaries stay profitable. Valuations continue to remain undemanding. Prefer ICICI Bank over...
|
|
28 Oct 2017
|
ICICI Bank
|
HDFC Securities
|
1402.20
|
364.00
|
300.95
(365.92%)
|
Target met |
Buy
|
|
|
Maintain BUY with a TP of Rs 364 (1.8x Sept-19 core ABV of Rs 142 + subs-value of Rs 107). After quite a few uninspiring quarters, ICICIBC showed evidence of recovery in 2QFY18. Loan growth resumed (+13% QoQ in the domestic book), costs crawled (+3% QoQ) and NIM was stable (3.3%). Slippages, mercifully, were at an 8-qtr low. Management utilised profits from the subsidiary stake sale to beef up coverage (59.3%, +410bps QoQ) and provided for NCLT a/cs two quarters in advance.
|
|
27 Oct 2017
|
ICICI Bank
|
Motilal Oswal
|
1402.20
|
355.00
|
300.95
(365.92%)
|
Target met |
Buy
|
|
|
ICICIBC reported 2QFY18 PAT of INR20.6b (19% miss), affected by elevated provisions; however, stable margins, in-line slippages and an improvement in the coverage ratio provided comfort. NII grew 9% YoY to INR57.09b (1.5% beat), while core fee growth remained soft at 9% YoY. NIM held stable at 3.27%, and management maintained its >3% NIM guidance for FY18. Business growth picked up, with the advances portfolio growing 4% QoQ (flattish in 1QFY18), led by continued traction in retail loans (+19% YoY; ~54% of total loans), and the corporate portfolio growing 5.6% QoQ. Deposit growth,...
|
|
27 Oct 2017
|
ICICI Bank
|
Sharekhan
|
1402.20
|
340.00
|
315.85
(343.94%)
|
Target met |
Buy
|
|
|
ICICI Bank
The total Provision coverage against the 12 accounts refererd to IBC/NCLT was 56.5% and the additional provision of Rs 651 crores (required over three quarters) were made in Q22018, utilizing the listing gains of its General Insurance subsidiary. Provision coverage ratio during the quarter improved by 410 BPS QoQ to 59.3%. The drilldown list during the quarter declined to Rs19590 crore from Rs20358 crore...
|
|
09 Oct 2017
|
ICICI Bank
|
Axis Direct
|
1402.20
|
|
271.85
(415.80%)
|
|
Mgmt Note
|
|
|
We met the management of ICICI Bank (ICICIBC) to get insights of the business and outlook on asset quality. Overall loan growth will remain soft due to run-down of overseas portfolio (15% in Q1FY18 vs. 24% in Q1FY16) but robust growth in retail/SME will keep domestic loan growth strong.
|
|
11 Sep 2017
|
ICICI Bank
|
Edelweiss
|
1402.20
|
362.00
|
291.00
(381.86%)
|
Target met |
Buy
|
|
|
ICICI Bank's Q1FY18 earnings were marginally lower than estimates, on soft core operating performance.
|
|
02 Aug 2017
|
ICICI Bank
|
Axis Direct
|
1402.20
|
350.00
|
301.60
(364.92%)
|
Target met |
Buy
|
|
|
ICICI Bank reported a soft Q1 with an in-line PAT (Rs 20.5 bn down 8% YoY), subdued advances growth (3% YoY) and 30 bps QoQ margin drop (NIM included 10 bps benefit from income tax refunds).
|
|
28 Jul 2017
|
ICICI Bank
|
HDFC Securities
|
1402.20
|
338.00
|
296.30
(373.24%)
|
Target met |
Buy
|
|
|
Maintain BUY with a revised SOTP of Rs 338 (1.9x FY19E core ABV of Rs 132 and sub-value of Rs 88/sh. ICICIBCs 1Q performance was a tad disappointing on the core front, as NIMs dipped and growth slowed optically. While the slippages were lower (despite one large non-watchlist NPA) and the restructured book almost halved the net stressed assets were stable, as watchlist increased 7% QoQ.
|
|
23 May 2017
|
ICICI Bank
|
HDFC Securities
|
1402.20
|
|
306.25
(357.86%)
|
Pre-Bonus/ Split |
Results Update
|
|
|
NII increased to Rs. 7097.66 Cr in Q4FY17 compared to Rs. 6454.4 Cr in Q3FY17.
|